147 related articles for article (PubMed ID: 17498552)
1. Automated Duet spot counting system and manual technologist scoring using dual-fusion fluorescence in situ hybridization (D-FISH) strategy: comparison and application to FISH minimal residual disease testing in patients with chronic myeloid leukemia.
Knudson RA; Shearer BM; Ketterling RP
Cancer Genet Cytogenet; 2007 May; 175(1):8-18. PubMed ID: 17498552
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of dual color-dual fusion translocation fluorescence in situ hybridization in the detection of bcr/abl fusion gene.
Wu B; Zhou S; Song L; Liu X
Zhonghua Zhong Liu Za Zhi; 2002 Jul; 24(4):364-6. PubMed ID: 12408765
[TBL] [Abstract][Full Text] [Related]
3. "Home-brew" FISH assay shows higher efficiency than BCR-ABL dual color, dual fusion probe in detecting microdeletions and complex rearrangements associated with t(9;22) in chronic myeloid leukemia.
Albano F; Anelli L; Zagaria A; Archidiacono N; Liso V; Specchia G; Rocchi M
Cancer Genet Cytogenet; 2007 Apr; 174(2):121-6. PubMed ID: 17452253
[TBL] [Abstract][Full Text] [Related]
4. A two-color BCR-ABL probe that greatly reduces the false positive and false negative rates for fluorescence in situ hybridization in chronic myeloid leukemia.
Grand FH; Chase A; Iqbal S; Nguyen DX; Lewis JL; Marley SB; Davidson RJ; Goldman JM; Gordon MY
Genes Chromosomes Cancer; 1998 Oct; 23(2):109-15. PubMed ID: 9739013
[TBL] [Abstract][Full Text] [Related]
5. [The application of fluorescence in situ hybridization in detecting chronic myeloid leukemia].
Qiu HR; Miao KR; Wang R; Qiao C; Zhang JF; Zhang SJ; Qian SX; Xu W; Li JY
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2009 Apr; 26(2):207-10. PubMed ID: 19350518
[TBL] [Abstract][Full Text] [Related]
6. [The application of dual fusion interphase fluorescence in situ hybridization probe in detecting minimal residual disease in chronic myeloid leukemia].
Du Q; Liu X; Song L; Meng F; Zhou S
Zhonghua Nei Ke Za Zhi; 2002 Dec; 41(12):801-4. PubMed ID: 12654231
[TBL] [Abstract][Full Text] [Related]
7. [Detection of bcr/abl fusion gene in chronic myeloid leukemia by fluorescence in situ hybridization and nested reverse transcription polymerase chain reaction].
Wu B; Zhou SY; Liu XL; Song LL; Zhang Y
Zhonghua Xue Ye Xue Za Zhi; 2003 May; 24(5):235-7. PubMed ID: 12859872
[TBL] [Abstract][Full Text] [Related]
8. [Monitoring of minimal residual disease in patients with chronic myeloleukemia: clinical value of real-time polymerase chain reaction].
Chelysheva EIu; Turkina AG; Misiurin AV; Aksenova EV; Domracheva EV; Zakharova AV; Khoroshko ND
Ter Arkh; 2007; 79(4):49-53. PubMed ID: 17564019
[TBL] [Abstract][Full Text] [Related]
9. Comparison of bone marrow high mitotic index metaphase fluorescence in situ hybridization to peripheral blood and bone marrow real time quantitative polymerase chain reaction on the International Scale for detecting residual disease in chronic myeloid leukemia.
Lundán T; Juvonen V; Mueller MC; Mustjoki S; Lakkala T; Kairisto V; Hochhaus A; Knuutila S; Porkka K
Haematologica; 2008 Feb; 93(2):178-85. PubMed ID: 18223279
[TBL] [Abstract][Full Text] [Related]
10. Interphase fluorescence in situ hybridization studies for the detection of 9q34 deletions in chronic myelogenous leukemia: a practical approach to clinical diagnosis.
Aoun P; Wiggins M; Pickering D; Foran J; Rasheed H; Pavletic SZ; Sanger W
Cancer Genet Cytogenet; 2004 Oct; 154(2):138-43. PubMed ID: 15474149
[TBL] [Abstract][Full Text] [Related]
11. Circulating myeloid dendritic cell directly isolated from patients with chronic myelogenous leukemia are functional and carry the bcr-abl translocation.
Orsini E; Calabrese E; Maggio R; Pasquale A; Nanni M; Trasarti S; Tafuri A; Guarini A; Foa R
Leuk Res; 2006 Jul; 30(7):785-94. PubMed ID: 16527350
[TBL] [Abstract][Full Text] [Related]
12. [Detection of bcr/abl fusion gene by dual color-dual fusion fluorescence in situ hybridization].
Liu XP; Li CW; Dai Y; Qin S; Xiao JG; Xu FY; Gong JY; Wang SP; Yu CL; Fan J; Wang JX
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Aug; 17(4):961-4. PubMed ID: 19698238
[TBL] [Abstract][Full Text] [Related]
13. Quantitative real-time RT-PCR monitoring of BCR-ABL in chronic myelogenous leukemia shows lack of agreement in blood and bone marrow samples.
Stock W; Yu D; Karrison T; Sher D; Stone RM; Larson RA; Bloomfield CD
Int J Oncol; 2006 May; 28(5):1099-103. PubMed ID: 16596225
[TBL] [Abstract][Full Text] [Related]
14. [Comparison and significance of DCDF probe and ES probe in the detection of BCR/ABL fusion gene].
DU QH; YING Y; CHEN XY; LI QS; WANG SQ; MO WJ
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2011 Apr; 28(2):220-2. PubMed ID: 21462140
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic role of conventional cytogenetics and fluorescence in situ hybridization (FISH) in chronic myeloid leukemia patients.
Jha CB; Kucheria K; Choudhary VP
Kathmandu Univ Med J (KUMJ); 2006; 4(2):171-5. PubMed ID: 18603893
[TBL] [Abstract][Full Text] [Related]
16. Automated fluorescent in situ hybridization (FISH) analysis of t(9;22)(q34;q11) in interphase nuclei.
Kajtár B; Méhes G; Lörch T; Deák L; Kneifné M; Alpár D; Pajor L
Cytometry A; 2006 Jun; 69(6):506-14. PubMed ID: 16646048
[TBL] [Abstract][Full Text] [Related]
17. "FISHing" to detect urinary and other cancers: validation of an imaging system to aid in interpretation.
Smith GD; Bentz JS
Cancer Cytopathol; 2010 Feb; 118(1):56-64. PubMed ID: 20099312
[TBL] [Abstract][Full Text] [Related]
18. Rapid detection of BCR-ABL fusion genes using a novel combined LUX primer, in-cell RT-PCR and flow cytometric method.
Shi Y; Li LZ; Sun JZ; Zhang T; Peng J; Xu CG
Ann Hematol; 2008 Jan; 87(1):35-41. PubMed ID: 17846772
[TBL] [Abstract][Full Text] [Related]
19. Qualitative and quantitative evaluation of the BCR-ABL fusion gene in chronic myelogenous leukemia by flourescence in situ hybridization and molecular genetic methods.
Ozemri Sag S; Yakut T; Gorukmez O; Gorukmez O; Ture M; Karkucak M; Gulten T; Ali R
Genet Test Mol Biomarkers; 2015 Oct; 19(10):584-8. PubMed ID: 26308792
[TBL] [Abstract][Full Text] [Related]
20. Interphase FISH for follow-up of Philadelphia chromosome-positive chronic myeloid leukemia treatment.
Douet-Guilbert N; Morel F; Le Charpentier T; Le Bris MJ; Herry A; Morice P; Bourquard P; Abgrall JF; Berthou C; De Braekeleer M
Anticancer Res; 2004; 24(4):2535-9. PubMed ID: 15330210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
